1. Hepatic elimination of renin was measured in 10 well-compensated cardiac patients with normal liver function during a control period and during a period of reduced hepatic plasma flow, induced by physical exercise (seven patients) or intravenous infusion of lysine vasopressin (three patients).
Introduction
R e i n is eliminated by the liver in animals and man (Heacox, Harvey & Vander, 1967; Christlieb, Couch, Amsterdam, Dobrzinsky & Hickler, 1968; Kokot, Kuska & Czekala, 1968) . In dogs acute reduction of the hepatic plasma flow (HPF) caused a fall in the hepatic clearance of renin, and it was concluded that a decreased hepatic inactivation rate of renin contributed to the elevated renin values after haemorrhage and sodium depletion (Johnson, Davis, Baumber & Schneider, 197 1) .
In several procedures leading to stimulation of renin, as in exercise, postural change, thermal stress, haemorrhage etc. there is also a reduction in HPF, so that it has been suggested that this reduction in HPF might contribute to the increase in renin (Kotchen, Hartley, Rice, Mougey, Jones & Mason, 1971; Finberg, Kratz, Gazit & Berlyne, 1974; Kosunen, Bakarinen, Kuoppasalmi & Adlercreutz, 1976) . We have now examined the influence of an acute reduction of HPF on the hepatic elimination of renin in man. In seven subjects HPF was reduced by physical exercise (Wade & Bishop, 1962) and in three subjects by intravenous infusion of lysine vasopressin, which appears to have no influence on the hepatic function, as assessed by galactose uptake and liver oxygen consumption (Jacobsen, Ranek & Tygstrup, 1969) .
Patients
Ten patients (four women and six men, aged 26-67 years), who were referred for haemodynamic investigation, were studied. Five had mitral valvular disease, two aortic valvular disease, one pulmonary valvular disease and benign essential hypertension, one cardiomyopathy, and one an innocent cardiac murmur. Seven were on maintenance treatment with diuretics and potassium supplementation: four patients (nos. 1, 7, 8 and 10) received bumetanide (2 mg daily); patient no. 2 received frusemide (240 mg) and triamterene (100 mg) daily; two patients (nos. 3 and 5) received bendroflumethiazide (10 mg) daily. Six patients (nos. 1, 2, 5, 6, 8 and 10) were on digitalis. Two patients (nos. 4 and 9) had no medication. None of the patients had clinical signs of overt heart failure or liver disease, all had normal plasma albumin concentration and the pressure gradient from the wedged to free position in the hepatic veins was 3 mmHg or less. All were on liberal salt and water intake.
Informed consent was obtained in each case. The project was approved by the heads of the two Divisions of the hospital and the medical director of the Department of Medicine regarding the scientific approach and the ethical problems.
Procedures
Right heart and hepatic venous catheterization was performed in the morning, 2 h after a light breakfast. Phenobarbitone (200 mg) was given orally 1 h before the haemodynamic investigation. The patients were supine during the examination.
Control period. Indocyanine green was infused intravenously (see below: Methods). Blood was sampled from the brachial artery and hepatic vein for oxygen saturation and determination of dye and plasma renin activity (PRA) every 5 min for at least 30 min. In the middle of the control period oxygen uptake was measured (by expired gas analysis), and heart rate and arterial pressure were recorded.
Exercise period. Seven patients performed supine exercise for 6-11 min on an ergometer bicycle (Siemens-Elema, Sweden). The load was set at two-thirds of the maximum load obtained at a previous exercise test carried out in the sitting position. Indocyanine green was continuously infused and arterial and hepatic venous blood were sampled for oxygen saturation, indocyanine green and PRA determination every 2-3 rnin during exercise. Oxygen uptake was measured from minute 3 to minute 5, according to the routine of the laboratory.
Lysine vasopressin infusions. After termination of the control period lysine vasopressin was added to the indocyanine green infusion to three patients for 10-15 min. Blood samples for oxygen saturation, indocyanine green and PRA determination were drawn every 5 min, and heart rate and arterial pressures recorded, but oxygen uptake was not determined. In patient no. 8 the infusion was interrupted for 5 min because of abdominal cramps. Cardiac arrhythmias were not observed.
Methods
A Cournand catheter (no. 7) was advanced from an antecubital vein into the major right hepatic vein. The catheter was wedged and then drawn back just enough for easy withdrawal of blood samples. A 20 cm polyethylene catheter was introduced into the brachial artery by the Seldinger technique. Pressures were measured with capacitance transducers (Hansen, 1949) . Expired air was collected into Douglas bags for 5 rnin at rest and for 3 min during exercise, oxygen concentration being measured by Haldane analysis and expired volume by a gasometer. Blood oxygen saturation was determined by an oximeter (Siemens-Elema, Sweden) and haemoglobin concentration with a photoelectric haemoglobinometer (Haemotest, Testa Laboratories, Denmark). Indocyanine green (1 mg/ml) in sodium chloride solution (154 mmol/l: saline) was administered by an infusion pump (1 ml/min) through a small indwelling needle placed in an antecubital vein of the opposite arm. After an equilibration for 15 rnin blood samples for determination of indocyanine green were drawn simultaneously from the hepatic vein and brachial artery. The plasma was separated immediately by centrifugation for 20 min and analysed in a Zeiss spectrophotometer at 800 and 900 nm for turbidity correction (Nielsen, 1963) .
PRA was measured by a radioimmunoassay (Haber, Koerner, Page, Kliman & Purnode, 1969) with the angiotensin I lZsI kit of NEN New England Nuclear, and with incubation at pH 6.0. Each plasma sample from one patient was measured in duplicate, the coefficient of variation of samples run within the same analysis being 3.3%. The normal range of PRA by this method is 0.52-2.2 pmol of angiotensin I h-I ml-I.
Synthetic lysine vasopressin (Vasopressin, Sandoz), dissolved in saline, was infused intravenously at a rate of 0.25 unit/min after a priming dose of 1 unit during the first minute. The activity of this vasopressin is controlled by a bioassay (U.S.P. XVII), the reference substance being the third international standard of oxytocic, vasopressor and antidiuretic substances.
Calculations and statistics
Hepatic plasma flow (the term conventionally used instead of the more correct term 'splanchnic plasma flow') was calculated for each sampling period as:
where AA is the change in the arterial concentration of dye, V the volume of distribution of dye, which is assumed to be plasma volume (in litres = 0.05 x body weight in kg), A and hV the mean concentrations of indocyanine green in arterial and hepatic vein plasma. The individual HPF values of the control, exercise, and lysine vasopressin infusion periods (Tables 1 and 2) are mean values of six (control), three or four (exercise) and two or three (LVP) sampling intervals. The calculation of HPF depends upon stable plasma concentrations of the test substance (Bradley, Ingelfinger, Bradley & Curry, 1945) , so that the validity of the method may be questioned when rapid fluctuations of plasma concentration occur. Such fluctuations must occur during brief periods of HPF reduction, the arterial concentration of indocyanine green rising when HPF falls and decreasing as flow returns to the control rate. In case of rapid changes of dye concentration, the volume of distribution may be overestimated, since the dye is not evenly distributed during such brief periods. The rather rough estimate of plasma volume represents another source of error, the correct factor probably being between 0-03 and 0.06 x body weight. However, since the arterial dye concentration largely stabilized within the exercise and lysine vasopressin infusion periods both errors are probably of limited importance. HPF values during exercise and during LVP infusion were also calculated from the relative changes in arterial-hepatic vein oxygen difference multiplied by values of HPF during the control study, on the assumption that the oxygen uptake of the liver remains constant (Jacobsen et al., 1969 ; Rowell, Blackmon & Bruce, 1964) .
The results have been evaluated statistically with linear regression analysis and by the Wilcoxon test for paired comparison (Keeping, 1962) .
Results
Arterial pressures, heart rate and oxygen uptake increased during exercise (P < 0.02, Table l), whereas HPF fell, on average to 61% (range 33-98%) of the control value in patients nos. 1-6, calculated by indocyanine green, and by 57% (range 38-66%), calculated by the changes in oxygen extraction of the liver. In patient no. 7 the HPF values calculated by dye became negative during exercise.
In all patients the arterial-hepatic vein PRA difference (PRA,-,,) was positive. Arterial PRA (PRA,), hepatic vein PRA (PRA,,), PRA,-,, and the hepatic renin extraction ratio (PRA,_,,,) all increased during exercise (P < 0.02, Table 1 ).
Systolic arterial pressure increased during in- fusion of lysine vasopressin and heart rate was unchanged (Table 2) . HPF during the infusion, as calculated with indocyanine green, fell to 31, 65 and 58% respectively of the control value, and to 53, 77 and 58% respectively of the control value as calculated by the changes in the oxygen extraction. PRA,-,, was positive in all three patients. PRA, was unchanged during lysine vasopressin infusion. PRA,, decreased, PRA,-,, and PRA,-,,,, increased in all three patients ( Table 2) .
HPF during exercise or infusion of lysine vasopressin, as calculated by indocyanine green, was correlated with that measured by the relative changes in oxygen extraction of the liver (Fig. 1 , r = 0.88, P < 0.01 if the negative value of patient no. 7 is omitted; if it is included, r = 0.83, The hepatic elimination rate of renin was closely correlated with PRA,, both in the control period and during exercise and infusion of lysine vasopressin [ Fig. 2 , which is a double logarithmic plot P < 0.01). to show the very wide range of values: the correlation is linear (r = 0.986, P < 0.001)l. C,,, decreased in four patients, increased in four and was unchanged in one (Tables 1 and 2 ). It was not calculated in patient no. 7 due to the negative HPF (indocyanine green) value during exercise. Fig. 3 shows that mean C,,, was unchanged when HPF fell to 45%, owing to a concurrent increase in the extraction ratio of PRA from 0.16 to 0.28.
Discussion
We have found a mean hepatic renin extraction ratio of 0.16 (range 0.05-0-35) in the control state, slightly lower than that previously reported in man (Christlieb et al., 1968: 0.26; Kokot et al., 1968: 0.29) . But it should be pointed out that there were very wide limits in the individual extraction ratios reported in those two studies, ranging from -0.26 to 0.59 and 0.0 to 0.59 respectively. Thus all the extraction ratio values of the present study are well within these limits. The mean values reported in dogs (Heacox et al., 1967: 0.28; Johnson et al., 1971: 0.25; Tapia, Kuster, Woods & Strong, 1973: 0.38 ) and rats (Horky, RojoOrtega, Rodriguez & Genest, 1970: 0-28) are also somewhat higher than that of the present study.
However, as the extraction ratio in an individual (dog or man) varies according to his hepatic blood flow at the time of measurement (Johnson et al., 1971 , and this study) the ratio is highly dependent on the experimental design. Since H P F is reduced by anaesthesia (Deutsch, 1967) , exercise and cardiac disease (Wade & Bishop, 1962 ) the lowest extraction ratios are to be expected in normal, resting, conscious individuals. In the present patients the rather low extraction ratio of renin can therefore not be attributed to the cardiac diseases.
The hepatic clearance of substances excreted by the liver with an extraction ratio of less than 0.30 (like renin) is expected to be independent of changes in HPF (Wilkinson & Shand, 1975) . This was confirmed by our finding of a constant hepatic CPRA, despite a marked decrease of HPF. The constant C,,, means that the renin elimination rate was independent of variations in HPF. Changes in HPF do not therefore contribute to the acute alterations in PRA during procedures which influence both renin release and HPF.
Our findings that C,,, was constant during reduction of HPF, and of a linear correlation between the hepatic elimination rate of renin and PRA, (Fig. 2) differ from the observations of Schneider, Davis, Baumber & Johnson (1970) and the study of Johnson et al. (1971) , who found that reduction of H P F after constriction of the hepatic artery and portal vein in anaesthetized dogs did not alter the hepatic extraction ratio of renin (Schneider ef al., 1970) . Furthermore, a reduction in HPF by haemorrhage of 30 ml/kg had no significant influence on the hepatic extraction ratio (Johnson et al., 1971) , leading to the conclusion that changes in C,,, may contribute to changes in peripheral PRA during procedures influencing HPF.
This discrepancy may be due to: differences between man and dog, and different experimental designs (haemorrhage vs exercise and infusion of lysine vasopressin), and also from a lack of steady state in renin release after a haemorrhage, where up to tenfold increases in peripheral PRA were observed (Johnson et al., 197 1) .
The reliability of the H P F values during brief periods of flow reduction may be questioned in the light of the increasing arterial concentration of indocyanine green. This increase may induce some error in the HPF calculation, which can be seen in the negative values of H P F calculated for patient no. 7 during exercise. In this patient the arterial dye concentration rose very rapidly (cf. the Methods section, 'Calculations and statistics'). However, the fairly strong correlation betweeen HPF calculated by indocyanine green and by the changes in oxygen extraction supports the reliability of the H P F values.
We conclude that the hepatic elimination rate of renin is a linear function of the peripheral PRA, and that CPRA is independent of HPF under physiological circumstances in man. An increase in renin release causes an increase in peripheral PRA, which, in turn, is followed by a rise in the hepatic elimination rate of renin, and a new steady state develops. Acute changes in PRA cannot be attributed to changes in the elimination rate of renin in man.
